Twin Tree Management’s Fortune Brands Innovations FBIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-200
Closed -$7.79K 1503
2026
Q1
$7.79K Buy
+200
New +$10.4K ﹤0.01% 1230
2024
Q3
Sell
-19,400
Closed -$1.26M 1603
2024
Q2
$1.26M Sell
19,400
-21,700
-53% -$1.57M ﹤0.01% 1025
2024
Q1
$3.48M Sell
41,100
-22,600
-35% -$1.8M 0.01% 895
2023
Q4
$4.85M Buy
+63,700
New +$4.19M 0.01% 885
2022
Q2
Sell
-30,069
Closed -$1.91M 1603
2022
Q1
$1.91M Sell
30,069
-26,091
-46% -$2.01M ﹤0.01% 1169
2021
Q4
$5.13M Sell
56,160
-22,698
-29% -$1.96M 0.01% 830
2021
Q3
$6.03M Buy
78,858
+66,690
+548% +$5.55M 0.01% 714
2021
Q2
$1.04M Hold
12,168
﹤0.01% 1011
2021
Q1
$997K Buy
+12,168
New +$921K ﹤0.01% 972
2020
Q3
Sell
-14,508
Closed -$793K 1345
2020
Q2
$793K Buy
+14,508
New +$675K ﹤0.01% 1095

Other funds holding FBIN

Twin Tree Management's FBIN Position: Q2 2026 in Review

Twin Tree Management reduced its Fortune Brands Innovations (FBIN) stake by 82% in Q2 2026, selling an estimated $151K and leaving 849 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Twin Tree Management first reported a position in FBIN in Q1 2015 and has held it in 18 quarters since. The position peaked at $10.6M in Q1 2022. 530 funds tracked by Wall St. Rank hold FBIN as of Q2 2026.

  • Twin Tree Management held 849 shares of Fortune Brands Innovations worth $46.6K as of Q2 2026.
  • Twin Tree Management sold 3,780 Fortune Brands Innovations shares in Q2 2026, an estimated $151K.
  • Fortune Brands Innovations made up ﹤0.01% of Twin Tree Management's portfolio in Q2 2026, its #1300 holding.
  • Twin Tree Management first reported a position in Fortune Brands Innovations in Q1 2015 and has held it in 18 quarters since.
  • Twin Tree Management's Fortune Brands Innovations position peaked at $10.6M in Q1 2022.
  • 530 funds tracked by Wall St. Rank held Fortune Brands Innovations as of Q2 2026.

Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.